GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

416

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Diabetes Mellitus Type 2
Interventions
DEVICE

Positive Airway Pressure therapy

Positive Airway Pressure (PAP) therapy initiated at Randomization and continued through the entire study duration (6 months), with instructions for use on a daily basis, during periods of sleep.

BEHAVIORAL

Lifestyle counseling

Lifestyle counseling: All subjects were counseled regarding adopting a healthy lifestyle and advised on the Heart Foundation, National Health and Medical Research Council, and American Diabetes Association nutrition and exercise recommendations.

Trial Locations (15)

2065

Royal North Shore Hospital, Sydney

3004

Baker IDI Heart and Diabetes Institute, Melbourne

3128

Eastern Clinical Research Unit, Box Hill

14609

Rochester Clinical Research, Rochester

21224

Johns Hopkins University, Baltimore

29201

SleepMed of South Carolina, Columbia

29407

SleepMed of West Ashley, Charleston

31201

SleepMed of Central Georgia, Macon

33134

Clinical Research of South Florida, Coral Gables

43210

OSU Sleep Medicine Program, Columbus

55416

International Diabetes Center, Saint Louis Park

78229

Cetero Research, San Antonio

92691

Mission Internal Medical Group, Mission Viejo

92951

Advanced Metabolic Care and Research Institute, Temecula

G1V 4G5

IUCPQ, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Royal North Shore Hospital

OTHER

collaborator

Baker Heart and Diabetes Institute

OTHER

collaborator

International Diabetes Center at Park Nicollet

OTHER

lead

ResMed

INDUSTRY